Araim Pharmaceuticals, Inc. operates as a biotechnology company that develops novel treatments for devastating injuries and chronic diseases. It provides ARA 290, a novel 11 amino acid peptide that activates the body’s natural repair system through the innate repair receptor, which is present only following injury, as well as activates anti-inflammatory, tissue protective, and reparative signaling pathways. The company was founded by Anthony Cerami and Michael Brines in 2006 and is headquartered in Tarrytown, NY.

Beijing Qi Yuan Yi De Pharmaceuticals Research Centre is a private company headquartered in Beijing, China, involved in pharmaceutical preparations.

Bayer Schering Pharma AG is a research-centered pharmaceutical company that was formed by the merger of Schering with Bayer on 29 December 2006. The company was originally founded in 1851 by Ernst Christian Friedrich Schering. The company employs more than 26,000 people in 140 subsidiaries all over the world. The company's headquarters are in Berlin-Wedding, Germany and the forerunner company Schering's annual gross revenue was nearly € 5 billion. They retain the largest German manufacturing facility which is located in Bergkamen. The company focuses on the business areas of gynaecology and andrology, oncology, and also special therapeutics, diagnostical devices, and nuclear medicine. Schering's best-known product is their line of combined oral contraceptive pills. Through Bayer Healthcare AG, Bayer Schering Pharma is a full member of the European Federation of Pharmaceutical Industries and Associations.

Jiangsu Zhihai Electronic Technology Co., Ltd., established on 2014-01-20, The scope of business includes the research of electronic technology;Computer Software and Hardware Research,design,Sales and technical consultation;medical technology research;Class II medical device research,Production,Wholesale and Retail;Medical Information Consulting Service;Nutrition and Health Consulting Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Established in 1945, Amorepacific is Korea’s No.1 beauty company and a blue-chip corporation. Amorepacific owns nearly 30 well-known brands and has been developing rapidly worldwide. Amorepacific pays great attention to product research and development through research centers located in Korea, France, Japan and Shanghai, to develop premium and high quality skincare and cosmetics products. The Group chose Hong Kong as a strategic bridgehead for the expansion of its presence across the Greater China region and the rest of the world. Two flagship brands - LANEIGE and Sulwhasoo, were introduced in Hong Kong in 2002 and 2004 respectively. The eponymous luxury brand – AMOREPACIFIC, was introduced in Hong Kong in 2014. In 2015, ETUDE HOUSE, a playful cosmetics brand, made its debut in the territory. In 2018, the Company set foot in the personal care product market, introducing the Group’s legendary hair care brand ‘Ryo’ into Hong Kong.

Boehringer Ingelheim International GmbH manufactures pharmaceutical prodcuts. It offers human and animal health products. The company was founded by Albert Boehringer in 1885 and is headquartered in Ingelheim, Germany.

CORIDEA is an idea generator, technology incubator and consulting firm that applies established technologies to new targets in the cardio-renal and cardio-pulmonary fields. Since its inception in 2003, Coridea has launched six startup companies including Ardian, CHF Solutions, and Respicardia (formerly, Cardiac Concepts). The $800 MM acquisition of Ardian by Medtronic marked the highest-priced venture capital-backed pre-revenue medical device acquisition to date. With 65 U.S. patents licensed by companies such as Evalve, Zoll Medical, Nephros, and PLC Medical; over $150 million in venture capital financing; and the invention of 2011 Edison Award-winning Symplicity® Catheter System™, Coridea is a leader in medical device innovation.

Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment engages in the development, production and marketing of prescription products for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology and ophthalmology; diagnostic imaging equipment and the necessary contrast agents. The Consumer Health segment manufactures and markets products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories. The CropScience segment includes seeds and plant traits, crop protection and nonagricultural pest control. The Animal Health segment offers prescription and nonprescription veterinary products. The Covestro segment provides raw materials for polyurethanes; polycarbonate granules and sheets; raw materials for coatings, adhesives and sealants; and by-products of polyether production and of chlorine production and use. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.

Beijing Zhizhong Energy Internet Research Institute Co., Ltd., established on 2015-02-04, Business scope includes power electronics,new energy,Energy storage system and battery materials,nanofiber material,Power System Automation and Informatization,Microgrid planning and operation control,Power Internet of Things and Cloud Computing,data center,Energy big data analysis,Electric Power Information Network,Technology development related to smart grid equipment manufacturing,technology transfer,Technical Services,technical consulting,Technical Training,Technical testing;Sales of machinery and equipment,Electrical Equipment,electronic product,Computer hardware and software and auxiliary equipment,knitted goods,daily necessities;Import and export,Technology Import and Export,Agent import and export.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

HANALL BIOPHARMA Co., Ltd. engages in the manufacture and sale of synthetic drug and biopharmaceuticals. It offers products such as medicine for digestion, high blood pressure, cerebrovascular disease, myocardial infarction, anti-diabetics, antibiotics, gastrointestinal, bone structure, erectile dysfunction, hives, and other pharmaceutical products. The company was founded by Byeong-Tae Kim on November 20, 1973 and is headquartered in Daejeon, South Korea.

ResMed provides sleep medications and non-invasive ventilation based on a visionary technology shifting diagnosis, treatment, and management of breathing sleep disorder. They treat sleep apnea, chronic obstructive pulmonary disease, and other chronic diseases.

Polarean designs and manufactures equipment for the production of hyperpolarized xenon or helium gas. When used in conjunction with MRI, these gases offer a fundamentally new and non-invasive functional imaging platform. Current investigational uses include identifying early diagnoses of respiratory diseases as well as monitoring progression and therapeutic response. In addition, xenon gas exhibits solubility and signal properties that enable it to be imaged within other tissues and organs. The company is pursuing regulatory approval for clinical use and also sells its hyperpolarizes and related equipment to academic research institutions worldwide. In addition to providing academic researchers with this equipment and support, Polarean Imaging plc. offers access to the intellectual property that provides freedom-to-operate in this technology area. Polarean was founded in 2011 and is headquartered in Durham, NC, USA.

OP2 Drugs SAS develops, researches and markets drugs. The company was founded by Frederic Marin and is headquartered in Pessac Cedex, France.

Xiamen Kedisen Technology Co., Ltd., established on 2020-09-28, Business scope includes general items:New material technology promotion service;Engineering and Technology Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Artificial intelligence application software development;software development;Wearable smart device sales;Sales of Class II Medical Devices;Optoelectronic Device Sales;AI Hardware Sales;Sales of high-performance fibers and composite materials;Information security equipment sales;Sales of electronic special materials.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Class III medical device business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments).

Chongqing Yidiankang Technology Co., Ltd., established on 2008-08-21, Business scope includes production;Class II Medical Devices:6821Medical electronic equipment(Biofeedback Depressor).(Operate according to the approved period of the license)*electronic product(Does not include electronic publications),Electrical Equipment,Computer hardware and software,Teaching and scientific research equipment,Biochemical reagents(Free of Hazardous Chemicals),Daily necessities(Does not contain plastic film),Iresearch on medical devices,manufacture,Sales and technical service.(Operations that are prohibited by laws and regulations within the above scope shall not be operated,Laws and regulations stipulate that approval should be obtained, but no business operation is allowed without approval)*

Sichuan Oriental Cat Architectural Design Co., Ltd., established on 2017-12-21, Business scope includes construction works,lighting project,Interior Decoration Engineering Design(Operating with a qualification certificate);graphic design,Advertising Design;Garden engineering,Environmental Engineering Design,Fire Engineering,Steel structure engineering,Building Curtain Wall Engineering Design(Operating with a qualification certificate).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Zhuhai Shunmei Medical Equipment Co., Ltd., established on 2001-02-16, The business scope includes the production and sale of self-produced Class II:6856Ward Nursing Equipment and Appliances.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Amarin Pharmaceuticals Ireland Ltd., a subsidiary of Amarin Corp. Plc, is a company headquartered in Ireland that manufactures bulk organic and inorganic medicinal chemicals.

Zhuozhirouyun (Xiamen) Technology Co., Ltd., established on 2022-02-16, Business scope includes general items:Engineering and Technology Research and Experimental Development;New material technology promotion service;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Artificial intelligence application software development;software development;Wearable smart device sales;Sales of Class II Medical Devices;Sales of Class I Medical Devices;Optoelectronic Device Sales;AI Hardware Sales;Information security equipment sales;Intelligent storage equipment sales;Artificial intelligence basic resources and technology platform;Integrated circuit chips and product sales;Intelligent robot sales;Artificial intelligence public data platform;Sales of industrial control computers and systems.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Class III medical device business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)The above business projects do not include projects within the scope of special management measures for foreign investment access